U.S. FDA Approves First Generic Version of Levaquin (MYL) (RDY) (TEVA) (AKRX)

The U.S. Food and Drug Administration today approved the first generic versions of Levaquin (levofloxacin), an antibiotic approved to treat certain infections in people ages 18 and older.

Generic tablet, oral solution, and injectable solution dosage forms of levofloxacin have been approved. The following 12 manufacturer's applications for generic levofloxacin have been approved:

• Akorn Inc. (Nasdaq: AKRX)
  
• Aurobindo Pharma Ltd.
  
• Dr. Reddy's Laboratories Ltd. (NYSE: RDY)
  
• Glenmark Generics Ltd.
  
• Hi-Tech Pharmacal Co. Inc.
  
• Lupin Ltd.
  
• Mylan Pharmaceuticals Inc. (NYSE: MYL)
  
• Sagent Strides LLC
  
• Sandoz Inc.
  
• Teva Pharmaceuticals USA (Nasdaq: TEVA)
  
• Torrent Pharmaceuticals Ltd.
  
• Wockhardt Ltd.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Mondi Says It Does Not Intend To Make An Offer For DS Smith
• Arista Networks (ANET) Announces COO Resignation
• HP Inc. (HPQ) Amends Bylaws to Decrease Board to 12 Seats